CINIE CINIE
中文 | English | Français | Русский
Home CINIE World Nuclear Fusion Nuclear Application

Search Results

Keyword:Technetium [99mTc]

Atom High-Tech Adds New Radiopharmaceutical Production Base in Changchun

Atom High-Tech Adds New Radiopharmaceutical Production Base in Changchun

The Jilin Provincial Medical Products Administration issued a public notice on August 21 stating that, in accordance with the Drug Administration Law of the People's Republic of China, the Regulations on the Administration of Radiopharmaceuticals, the Measures for the Supervision and Administration of Drug Production, and other relevant provisions, following on-site inspection and review approval, it intends to issue the Radiopharmaceutical Production License to Changchun Atom High-Tech Pharmaceutical Co., Ltd. The public notice period is 5 working days, subject to public supervision. The notice information shows that the registered address of Changchun Atom High-Tech Pharmaceutical Co., Ltd. is located at No. 770 Shengye Road, Beihu Science and Technology Development Zone, Changchun City, Jilin Province, and the proposed production address for the license is consistent with the registered address. The proposed production scope for this license is small-volume injections for in vivo radiopharmaceuticals, involving products such as Sodium Pertechnetate [99mTc] Injection, Technetium [99mTc] Methylenediphosphonate Injection, Technetium [99mTc] Methoxyisonitrile Injection, Technetium [99mTc] Pentetate Injection, Technetium [99mTc] Ethyl Cysteinate Dimer Injection, and Technetium [99mTc] Etifenin Injection.

2026-08-24

Reading Ranking

  • 1 New Mexico Approves Radioactive Materials Licence for Pacific Fusion
  • 2 US Nuclear Regulatory Commission Delays Review Milestone for Orano Enrichment Plant
  • 3 Poland's Nuclear Power Program Advances Long-Lead Item Procurement for First Plant
  • 4 U.S. Department of Energy Opens Lux Supercomputer to Aid Fusion Design
  • 5 Middle East Powers Accelerate Civil Nuclear Energy Strategic Deployment
  • 6 "Nuclea Energy" Acquires Moltex Nuclear Technology Assets
  • 7 CNNC Fifth Construction Company Completes Ring Rail Assembly for Jinqimen Unit 1
  • 8 Oklo Partners with U.S. Forged Rings to Reshape Domestic Nuclear Manufacturing
  • 9 ENTRA1 Energy Partners with Sargent & Lundy to Advance SMR Deployment
  • 10 France Releases Ten-Year Nuclear Fusion Energy Development Strategy Roadmap
  • 11 Asia's Nuclear Power Expansion: When Will Coal and LNG Demand Shift from "Slower Growth" to "Actual Decline"?
  • 12 Kentucky Proposes Prosperity One Nuclear Power Project
  • 13 IAEA Completes Nuclear Safety Review of Jordan
  • 14 Swedish and UK Companies Sign Advanced Nuclear Fuel Supply Agreement
  • 15 Ontario Power Generation Advances Darlington SMR Budget Update
CINIE

Organizing Committee of the Shenzhen Nuclear Expo

Telephone: +86 10-67808008

+86 10-68808008

Email: info@cinie.net

CINIE

Event Overview Support Services Highlights Archive Contact Us

World Nuclear

China Nuclear Power News World Nuclear Power News Expert Views Nuclear Power Technology

Fusion

China Fusion World Fusion Big Science Facilities ITER Program Business & Capital

Nuclear Application

Medical Scientific Research Environmental Protection Industry Food Agriculture Security
About us | All rights reserved
CINIE All rights reserved 2026 ICP License:京ICP备12027382号-9